Summary
AmerisourceBergen Corporation (COR) reported a solid financial performance for the quarter ended June 30, 2010, demonstrating growth in revenue and operating income compared to the prior year. Revenue increased by 6.6% to $19.6 billion, driven by strong performance in its Pharmaceutical Distribution segment, particularly within AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG). The company also saw a significant improvement in gross profit margin, up 18 basis points to 3.00%, largely attributed to the robust performance of its generic programs and a notable benefit from a new generic oncology drug launch. This growth, coupled with operating expense leverage, led to a 32.3% increase in operating income for the quarter. From a balance sheet perspective, the company maintained a strong liquidity position with substantial cash and cash equivalents, while also actively managing its debt structure. AmerisourceBergen continued its commitment to shareholder returns through share repurchases and dividend increases. Despite the positive financial trends, investors should remain aware of ongoing legal proceedings and potential risks outlined in the filing, which could impact future results.
Financial Highlights
55 data points| Revenue | $19.60B |
| Cost of Revenue | $19.01B |
| Gross Profit | $588.37M |
| SG&A Expenses | $289.29M |
| Operating Income | $281.85M |
| Net Income | $163.21M |
| EPS (Basic) | $0.58 |
| EPS (Diluted) | $0.57 |
| Shares Outstanding (Basic) | 281.19M |
| Shares Outstanding (Diluted) | 286.69M |
Key Highlights
- 1Revenue for the quarter increased by 6.6% to $19.6 billion, driven by growth in both ABDC and ABSG segments.
- 2Gross profit increased by 13.3% to $588.4 million, with gross profit margin improving by 18 basis points to 3.00%, benefiting from generic programs and a new generic oncology drug launch.
- 3Operating income saw a substantial increase of 32.3% to $281.9 million, reflecting revenue growth and improved operating expense leverage.
- 4Diluted earnings per share from continuing operations rose to $0.57 from $0.42 in the prior year's quarter.
- 5The company repurchased $350.3 million of its common stock during the nine months ended June 30, 2010, demonstrating a commitment to shareholder value.
- 6Cash and cash equivalents stood at $1.31 billion at the end of the period, indicating a strong liquidity position.
- 7The company is actively managing its debt, with total debt at $1.36 billion and significant availability under its revolving credit and securitization facilities.